MARC Coalition Holds Initial Meeting With CMS; Announces N...(imbursement and ensure that the secondar...),Health
Navigation Links
MARC Coalition Holds Initial Meeting With CMS; Announces New Members
Date:1/8/2009
imbursement and ensure that the secondary payer program works effectively, efficiently and economically.
Risk managers and reporting entities interested in joining MARC can visit www.marccoalition.com or send an e-mail to info@marccoalition.com.
'/>"/>
| SOURCE MARC Coalition Copyright©2009 PR Newswire. All rights reserved |
Related medicine news :
1. Coalition for Pulmonary Fibrosis Celebrates Landmark Year for Awareness, Advocacy, Research
2. Reality Coalition applauds FDA
3. California Health Industry Leaders Help Launch National CEO Coalition for Health Reform
4. Coalition to Salute Americas Heroes(TM) Hosts Record Turnout of Wounded Veterans, Families for 2008 Road to Recovery Conference & Tribute
5. Video: Childhood Influenza Immunization Coalition Supports Second Annual Childrens Flu Vaccination Day
6. MARC Coalition Formed to Advocate for Medicare Secondary Payor Reform
7. Virginia Business Coalition on Health Issues Statement of Support for Hospital Improvement
8. Audio: NACCP, Families Fighting Flu, and the Childhood Influenza Immunization Coalition Team Up to Educate Families About Annual Childhood Flu Vaccination
9. NACCP, Families Fighting Flu, and the Childhood Influenza Immunization Coalition Team Up to Educate Families About Annual Childhood Flu Vaccination
10. The Deaf Bilingual Coalition responds to HEAR Indiana and "Doing Deaf Differently"
11. Coalition Asks Bishops to Take Politicians to Task
Post Your Comments:
Breaking Medicine News(10 mins):Health News:Late-breaking brain and behavior research presented at ACNP annual meeting this week 2Health News:Nonprofit Partners With PR Company and Gains International Attention 2Health News:Friends Without A Border's First Annual Los Angeles Gala to be Held at Hollywood Roosevelt Hotel With Special Guest Performance by Robin Thicke 2Health News:Friends Without A Border's First Annual Los Angeles Gala to be Held at Hollywood Roosevelt Hotel With Special Guest Performance by Robin Thicke 3Health News:AdCare Health Systems Completes Private Placement to Fund Aggressive Growth Initiatives 2Health News:AdCare Health Systems Completes Private Placement to Fund Aggressive Growth Initiatives 3Health News:Vitamin D Linked to Survival in Lymphoma Patients 2
[0] Late-breaking brain and behavior research presented at ACNP annual meeting this week[0] Nonprofit Partners With PR Company and Gains International Attention[0] Friends Without A Border's First Annual Los Angeles Gala to be Held at Hollywood Roosevelt Hotel With Special Guest Performance by Robin Thicke[1] AdCare Health Systems Completes Private Placement to Fund Aggressive Growth Initiatives[0] Vitamin D Linked to Survival in Lymphoma Patients
Other Medicine News:Health News:Better Understanding of Quality of Life Assessments 2Health News:Better Understanding of Quality of Life Assessments 3Health News:Are One-Third of Costly Implanted Heart Devices Unnecessary? 2Health News:Are One-Third of Costly Implanted Heart Devices Unnecessary? 3
Breaking Medicine Technology:Anesiva Completes Sale of its Zingo(TM) Assets to Powder Pharmaceuticals and Lee's Pharmaceuticals 2St. Luke's Hospital Acquires Pioneering Technology From BrainLAB 2St. Luke's Hospital Acquires Pioneering Technology From BrainLAB 3Al Novak Elected Chairman of the Board of OrbusNeich Medical 2Why Swine Flu Differs From Seasonal Flu 50671 1Why Swine Flu Differs From Seasonal Flu 50671 2Why Swine Flu Differs From Seasonal Flu 50671 3Prostate cancer patients disease free after five years likely to be disease free after 10 years 50669 1CyberGlove Systems Hosts Worldwide Contest for New Motion Capture Technology Applications 50667 1CyberGlove Systems Hosts Worldwide Contest for New Motion Capture Technology Applications 50667 2CyberGlove Systems Hosts Worldwide Contest for New Motion Capture Technology Applications 50667 3
Other Medicine Technology:Further Clinical Testing of BZL101 in Advanced Breast Cancer Demonstrates Favorable Efficacy and Toxicity Profiles 2Further Clinical Testing of BZL101 in Advanced Breast Cancer Demonstrates Favorable Efficacy and Toxicity Profiles 3Further Clinical Testing of BZL101 in Advanced Breast Cancer Demonstrates Favorable Efficacy and Toxicity Profiles 4Clinical Proof of Concept for TGF-beta 2-Inhibitor AP 12009 in Phase Iib EMEA provides Guidance on Phase III Design and Approval Requirements 2Clinical Proof of Concept for TGF-beta 2-Inhibitor AP 12009 in Phase Iib EMEA provides Guidance on Phase III Design and Approval Requirements 3Clinical Proof of Concept for TGF-beta 2-Inhibitor AP 12009 in Phase Iib EMEA provides Guidance on Phase III Design and Approval Requirements 4
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |